(0.34%) 5 117.11 points
(0.33%) 38 365 points
(0.38%) 15 989 points
(-0.97%) $83.04
(5.30%) $2.03
(0.35%) $2 355.40
(0.49%) $27.67
(4.13%) $960.15
(-0.27%) $0.932
(-0.45%) $10.98
(-0.57%) $0.796
(1.66%) $93.40
@ $8.22
発行日: 14 2月 2024 @ 23:30
リターン: 0.73%
前回のシグナル: 2月 13 - 23:30
前回のシグナル:
リターン: -2.26 %
Live Chart Being Loaded With Signals
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients...
Stats | |
---|---|
本日の出来高 | 209 526 |
平均出来高 | 793 700 |
時価総額 | 428.73M |
EPS | $0 ( 2024-02-28 ) |
次の収益日 | ( $-0.190 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.34 |
ATR14 | $0.0170 (0.21%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Hanna John Walter Jr | Sell | 0 | Common Stock |
2024-04-15 | Hanna John Walter Jr | Sell | 700 706 | Employee Stock Option (right to buy) |
2024-04-18 | Jain Abhishek | Sell | 323 | Common Stock |
2024-04-08 | Jain Abhishek | Sell | 235 | Common Stock |
2024-02-01 | Jain Abhishek | Buy | 174 520 | Common Stock |
INSIDER POWER |
---|
13.25 |
Last 100 transactions |
Buy: 1 682 772 | Sell: 893 426 |
ボリューム 相関
CareDx Inc 相関
10 最も正の相関 | |
---|---|
INFI | 0.962 |
BAND | 0.958 |
NKTR | 0.955 |
FULC | 0.954 |
INGN | 0.953 |
ORGS | 0.953 |
UPLD | 0.949 |
JAGX | 0.941 |
MICS | 0.936 |
GOODM | 0.934 |
10 最も負の相関 | |
---|---|
TIG | -0.918 |
TYHT | -0.915 |
MYRG | -0.913 |
SGEN | -0.911 |
OPCH | -0.906 |
PPYAU | -0.898 |
APEN | -0.889 |
RELY | -0.889 |
KNBE | -0.882 |
ALTR | -0.88 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
CareDx Inc 相関 - 通貨/商品
CareDx Inc 財務諸表
Annual | 2023 |
収益: | $280.32M |
総利益: | $175.87M (62.74 %) |
EPS: | $-3.54 |
FY | 2023 |
収益: | $280.32M |
総利益: | $175.87M (62.74 %) |
EPS: | $-3.54 |
FY | 2022 |
収益: | $321.79M |
総利益: | $209.58M (65.13 %) |
EPS: | $-1.440 |
FY | 2021 |
収益: | $296.40M |
総利益: | $199.01M (67.14 %) |
EPS: | $-0.582 |
Financial Reports:
No articles found.
CareDx Inc
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。